Name of the Trial
Yeast-Brachyury Vaccine in Treating Patients with Locally Advanced Chordoma That Cannot Be Removed by Surgery (NCI-15-C-0118). See the protocol abstract.
Dr. Christopher Heery
Credit: Chris Heery
Principal Investigator
Christopher Ryan Heery, NCI Center for Cancer Research
Why This Trial Is Important
Chordoma is a rare type of cancer that forms along the spine or at the base of the skull. About 300 people in the United States are diagnosed with chordoma each year. Although this cancer is slow growing, it gradually extends into nearby bone and soft tissue, and it can spread (metastasize) to other parts of the body. Fewer than 50 percent of patients with chordoma survive 10 years after diagnosis.
from Cancer Information - Vaccine Therapy for Unresectable Chordoma - National Cancer Institute
0 коммент.